Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Saved in:
| Title: | Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor. |
|---|---|
| Authors: | Babcock, Michael C.1, Mikulka, Christina R.2, Wang, Bing1, Chandriani, Sanjay1, Chandra, Sundeep1, Xu, Yue1, Webster, Katherine1, Feng, Ying1, Nelvagal, Hemanth R.3, Giaramita, Alex1, Yip, Bryan K.1, Lo, Melanie1, Jiang, Xuntian2, Chao, Qi1, Woloszynek, Josh C.1, Shen, Yuqiao1, Bhagwat, Shripad1, Sands, Mark S.2,4, Crawford, Brett E.1 bcrawford@bmrn.com |
| Source: | Scientific Reports. 7/14/2021, Vol. 11 Issue 1, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
